Business
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy.
About this update from Zomedica Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy\r\n \r\n \r\n\r\n\r\nZomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy\r\n\r\n\r\n\r\n\r\n\r\nInnovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care ANN ARBOR, MI / ACCESS Newswire / May 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) (\"Zomedica\" or the \"Company\"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Equine Asthma Clinical Registry. This pioneering program leverages PulseVet® shock wave therapy to offer a non-invasive, drug-free treatment alternative for horses suffering from asthma.\r\n Equine asthma is a common yet often underdiagnosed condition, affecting an estimated 15% of horses over the age of seven. The chronic respiratory disease can significantly impact performance, comfort, and quality of life, especially in athletic and aging horses. Zomedica's Equine Asthma Clinical Registry aims to uncover better treatment strategies through real-world clinical evidence using the PulseVet system.\r\n Recent clinical studies have demonstrated that electrohydraulic extracorporeal shock wave therapy (ESWT) using the PulseVet device can significantly improve clinical signs in horses diagnosed with respiratory conditions. To date, 58 horses have completed treatment for respiratory conditions, with no reported adverse events.\r\n Dr. Beau Whitaker, DVM, of Brazos Valley Equine Hospital, commented, \"We've observed measurable reductions in respiratory effort, cough frequency, and overall clinical signs following ESWT treatment. It's a promising adjunct therapy for managing equine asthma.\"\r\n Veterinary clinics can enroll up to 20 horses, contributing to vital research while receiving product credits. Participants are required to complete three scheduled visits per horse over a 4-6 week period, with assessments conducted at each visit.\r\n \"The launch of this clinical registry marks an important milestone in our commitment to advancing patient care. By systematically collecting real-world data for the treatment of equine asthma, we aim to generate critical insight...